latest news releases from the newsroom
Nucleoside analogue reverse transcriptase inhibitor 204937 (MIV-210) presented at GlaxoSmithKline R&D-day
HUDDINGE, Sweden, Dec. 05, 2003 (PRIMEZONE) -- GlaxoSmithKline (GSK) and Medivir entered a licensing agreement for MIV- 210 a nucleoside analogue reverse transcriptase inhibitor (NRTI), in May 2003. GSK is responsible for pharmaceutical development and are having exclusive, worldwide marketing rights, except for the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), which have been retained by Medivir.
Sectra Increases Focus on UK Defense Market
LINKOPING, Sweden, Dec. 05, 2003 (PRIMEZONE) -- IT and medical technology company Sectra is increasing its focus on the UK defense and government authorities market for secure communications systems and is establishing a new company, Sectra Communications Ltd., with office in central Cheltenham, England.
Observer Makes the Previously Announced Directed New Share Issue of Two Million Shares
STOCKHOLM, Sweden, Dec. 05, 2003 (PRIMEZONE) -- The Board of Directors of Observer AB has decided on a directed new share issue of 2,000,000 shares to a limited number of Swedish and foreign institutional investors. The decision is based on an authorization from the Annual General Meeting held on May 6, 2003. The purpose of the new share issue is to finance part of the acquisition of the U.S. based MediaMap as announced on 3 December 2003. The shares have been placed at a price of SEK 33.90 per share and will raise approximately SEK 68 million to the company, before expenses related to the issue. Up until the completion of the placing of shares, the volume weighted average price for the Observer share on Stockholmsborsen (Stockholm stock exchange) on 4 December 2003 was SEK 34. After the new share issue, the total number of shares outstanding in Observer will amount to 69,957,325 shares.
F. Hoffmann-La Roche AG
Roche Files Marketing Application for Avastin with European Health Authorities
BASEL, Switzerland, Dec. 05, 2003 (PRIMEZONE) -- Roche today announced the submission of a Marketing Authorisation application to the European Union for Avastin (bevacizumab, rhuMAb-VEGF) as a treatment for first-line metastatic colorectal cancer in combination with chemotherapy. The application is based on data from a pivotal clinical study of over 900 patients on Avastin who experienced improved survival benefit compared to chemotherapy treatment alone. A safety database of more than 1,000 patients who received Avastin in clinical trials is also supporting the submission.
The Adventures of Bruce Mottlewaite -- New book features charming young psychic and his grandmother
BARNET, England, Dec. 4, 2003 (PRIMEZONE) -- After many years in a dull job, author Karen Ann Porter decided to explore her creative side. Suffering with painful osteoarthritis, she was inspired to write and struggled forward, even through a major surgery, to bring her characters to life. Porter's new book, Bruce Mottlewaite and Alice (now available through 1stBooks), was inspired by a friend's young son and is loosely based on a true story, though names have been changed.
Chronicles of Hope -- Author Collects E-Mails Detailing Son's Battle with Rare Disease
GOODLETTSVILLE, Tenn, Dec. 04, 2003 (PRIMEZONE) -- Sometimes, out of one person's pain springs a well of hope and inspiration for thousands. Alan Joyce struggled in the darkness of his son's disease. What began as messages to friends and family updating the condition of his son, Andy, blossomed into a prayer circle that included thousands. Andy's E-Mails (now available through 1stBooks), written by Joyce, is a collection of those correspondences.
A Hit Musical Duo's Off Stage Story -- Surf music pair Jan & Dean's roller coaster career described in new book
TAMPA, Fla., December 4, 2003 (PRIMEZONE) -- The hit musical duo Jan & Dean, known for their surfing tunes in the '50s, '60s and beyond, are still recognized as two superstars of their time. However, many people don't know their inspiring off stage story. Author Mark Thomas Passmore tells Jan Berry and Dean Torrence's complete story, including their discovery as teenagers, their numerous hits and the devastating car crash that left Jan, the creative arm of the group, near death in Dead Man's Curve and Back: The Jan & Dean Story (now available through 1stBooks).